Skip to main navigation Skip to search Skip to main content

Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines

  • Ioana Agache
  • , Yang Song
  • , Margarita Posso
  • , Pablo Alonso-Coello
  • , Claudio Rocha
  • , Ivan Solà
  • , Jessica Beltran
  • , Cezmi A. Akdis
  • , Mubeccel Akdis
  • , Knut Brockow
  • , Tomas Chivato
  • , Stefano del Giacco
  • , Thomas Eiwegger
  • , Kilian Eyerich
  • , Ana Giménez-Arnau
  • , Jan Gutermuth
  • , Emma Guttman-Yassky
  • , Marcus Maurer
  • , Graham Ogg
  • , Peck Y. Ong
    • Liam O’Mahony, Jürgen Schwarze, Thomas Werfel, Carlos Canelo-Aybar, Oscar Palomares, Marek Jutel
  • Transilvania University of Brasov
  • Research Institute of the Santa Creu i Sant Pau Hospital
  • Hospital del Mar
  • Biomedical Research Networking Center in Epidemiology and Public Health (CiberESP)
  • University of Zurich
  • Christine Kühne – Center for Allergy Research and Education
  • Technical University of Munich
  • CEU Universities
  • University of Cagliari
  • University of Toronto
  • Autonomous University of Barcelona
  • Vrije Universiteit Brussel
  • Icahn School of Medicine at Mount Sinai
  • Charité – Universitätsmedizin Berlin
  • University of Oxford
  • University of Southern California
  • University of Edinburgh
  • Hannover Medical School
  • Complutense University
  • University of Wrocław
  • “ALL-MED” Medical Research Institute

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology